Screening for haemoglobin disorders: One size may not fit all-Reference-Cited by-同舟云学术

Screening for haemoglobin disorders: One size may not fit all

Published:2023-10-25 Issue:1 Volume:204 Page:26-28
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shook Lisa M.¹²³^ORCID,Ware Russell E.¹²³⁴

Affiliation:

1. Division of Hematology, Department of Pediatrics Cincinnati Children's Hospital Medical Centre Cincinnati Ohio USA

2. Comprehensive Sickle Cell Centre, Cincinnati Children's Hospital Medical Centre Cincinnati Ohio USA

3. Department of Pediatrics College of Medicine, University of Cincinnati Cincinnati Ohio USA

4. Global Health Centre, Cincinnati Children's Hospital Medical Centre Cincinnati Ohio USA

Abstract

Accurate laboratory screening for sickle cell disease and other haemoglobin disorders is expanding worldwide. Two new reports describe different methods and strategies for screening in Mali and Denmark, respectively, and their encouraging results suggest that countries should tailor their screening programmes according to local needs, resources and opportunities.Commentary on: Guindo et al. Potential for a large‐scale newborn screening strategy for sickle cell disease in Mali: a comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood. Br J Haematol 2024;204:337–345 and Gravholt et al. The Danish national haemoglobinopathy screening programme: report from 16 years of screening in a low‐prevalence, non‐endemic region. Br J Haematol 2024;204:329–336.

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19160

Reference9 articles.

1. Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades

2. Evaluation of newborn sickle cell screening programme in England: 2010–2016;Streetly A;Arch Dis Child,2018

3. Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference

4. Exploring the Effectiveness of Mandatory Premarital Screening and Genetic Counselling Programmes for β-Thalassaemia in the Middle East: A Scoping Review

5. Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants